secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001213900-24-016507
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma announces 1-for-5 reverse stock split effective March 6, 2024
--------------------------------------------------------------------------

- Reverse split at 1-for-5 ratio, effective March 6, 2024; every 5 pre-split shares convert to 1 post-split share.
- No fractional shares issued; any fractional shares will be rounded up to the next whole number.
- Trading continues on NYSE American under symbol CPHI; new CUSIP is 16941T 302.
- Split approved by Board on Oct 16, 2023 and by stockholders on Dec 17, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024016507/0001213900-24-016507-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024016507/ea0200603-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-016507

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer